Jinsong Hou

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

Authors' Reply "Tumor Budding Is a Promising Indicator for Elective Neck Dissection in Node-Negative Early-Stage Oral Squamous Cell Carcinoma: A Retrospective Cohort Study".

Authors' Reply "Tumor Budding Is a Promising Indicator for Elective Neck Dissection in Node-Negative Early-Stage Oral Squamous Cell Carcinoma: A Retrospective Cohort Study".

Journal: Oral diseases

Published: July 10, 2026

Improved risk stratification for oral tongue squamous cell carcinoma using deep learning-based MRI classifier and pathological markers to guide postoperative radiotherapy: A multicenter cohort study.

Improved risk stratification for oral tongue squamous cell carcinoma using deep learning-based MRI classifier and pathological markers to guide postoperative radiotherapy: A multicenter cohort study.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: April 15, 2026

Tumor Budding Is a Promising Indicator for Elective Neck Dissection in Node-Negative Early-Stage Oral Squamous Cell Carcinoma: A Retrospective Cohort Study.

Tumor Budding Is a Promising Indicator for Elective Neck Dissection in Node-Negative Early-Stage Oral Squamous Cell Carcinoma: A Retrospective Cohort Study.

Journal: Oral diseases

Published: January 23, 2026

Stage migration and prognostic refinement of oral squamous cell carcinoma under the AJCC 8th edition staging system: a retrospective cohort study with additional evaluation using the SEER database.

Stage migration and prognostic refinement of oral squamous cell carcinoma under the AJCC 8th edition staging system: a retrospective cohort study with additional evaluation using the SEER database.

Journal: BMC oral health

Published: January 16, 2026

Predicting survival in oral squamous cell carcinoma via integrated analysis of tumor budding and tertiary lymphoid structures.

Predicting survival in oral squamous cell carcinoma via integrated analysis of tumor budding and tertiary lymphoid structures.

Journal: Frontiers in oncology

Published: December 24, 2025

FB23-2 and Cisplatin Synergize to Inhibit Head and Neck Squamous Cell Carcinoma by Targeting the XPF/ERCC1 Complex.

FB23-2 and Cisplatin Synergize to Inhibit Head and Neck Squamous Cell Carcinoma by Targeting the XPF/ERCC1 Complex.

Journal: Cancer science

Published: October 24, 2025

Mapping Artificial Intelligence Research in Oral and Maxillofacial Surgery: A Bibliometric Analysis.

Mapping Artificial Intelligence Research in Oral and Maxillofacial Surgery: A Bibliometric Analysis.

Journal: International dental journal

Published: October 05, 2025

PLS3 Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Head and Neck Squamous Cell Carcinoma.

PLS3 Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Head and Neck Squamous Cell Carcinoma.

Journal: Cancers

Published: May 06, 2025

Liquid‑liquid phase separation of PHLDB2 promotes oral squamous cell carcinoma metastasis through regulating epithelial mesenchymal transition and PIK3CA expression.

Liquid‑liquid phase separation of PHLDB2 promotes oral squamous cell carcinoma metastasis through regulating epithelial mesenchymal transition and PIK3CA expression.

Journal: Molecular medicine reports

Published: April 28, 2025

Cancer-associated fibroblasts promote oral squamous cell carcinoma progression by targeting ATP7A via exosome-mediated paracrine miR-148b-3p.

Cancer-associated fibroblasts promote oral squamous cell carcinoma progression by targeting ATP7A via exosome-mediated paracrine miR-148b-3p.

Journal: Cellular signalling

Published: May 17, 2024

Lactylome analyses suggest systematic lysine-lactylated substrates in oral squamous cell carcinoma under normoxia and hypoxia.

Lactylome analyses suggest systematic lysine-lactylated substrates in oral squamous cell carcinoma under normoxia and hypoxia.

Journal: Cellular signalling

Published: March 29, 2024

Retinoic Acid Upregulates METTL14 Expression and the m6A Modification Level to Inhibit the Proliferation of Embryonic Palate Mesenchymal Cells in Cleft Palate Mice.

Retinoic Acid Upregulates METTL14 Expression and the m6A Modification Level to Inhibit the Proliferation of Embryonic Palate Mesenchymal Cells in Cleft Palate Mice.

Journal: International journal of molecular sciences

Published: March 19, 2024

Showing 1-12 of 57

Last Updated: 09/26/2026